Filing Details

Accession Number:
0001458177-11-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-04 17:32:36
Reporting Period:
2011-02-02
Filing Date:
2011-02-04
Accepted Time:
2011-02-04 17:32:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333763 Chelsea Therapeutics International Ltd. CHTP Biological Products, (No Disgnostic Substances) (2836) 203174202
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239242 E Bryan Roberts C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1365618 D Anders Hove C/O Venrock
530 Fifth Avenue, 22Nd Floor
New York NY 10036
No No Yes No
1458177 Venrock Healthcare Capital Partners Lp C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1479354 Vhcp Co-Investment Holdings, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1479355 Vhcp Management, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-02 75,000 $5.00 5,189,934 No 4 P Indirect By Fund
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Fund
Footnotes
  1. Consists of 4,387,367 shares of common stock held directly by Venrock Healthcare Capital Partners, L.P. ("VHCP") and 802,567 shares of common stock held directly by VHCP Co-Investment Holdings, LLC ("VHCP Co-Investment"). VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and VHCP Co-Investment and may be deemed to beneficially own these shares. Messrs. Anders Hove and Bryan Roberts are the managing members of VHCP Management and may be deemed to beneficially own these shares. Each reporting person disclaims beneficial ownership of these shares, except to the extent of his or its respective pecuniary interest therein.